Biotech China 2014

Profile Details
Christine Chung
Affiliations:

Vanderbilt University

University of California

 
2220 Pierce Ave., 777 PRB
Nashville, TN 37232-6307 USA
Phone: 615-322-6515
Fax: 615-343-7602
My Blogs:
 
Age:
Bio:
 
Specialty:
Cancer Biology
 
Presented at Events Covering:
Biology, Cancer Biology, Genomics, Hematology, Molecular Biology, Oncology, Proteomics, Translational Research
 
Areas of Interest:
oncology
 
Hobbies:
 
General Comments:
BSN Rank: 169 / 2885 (What's this?)
Accomplish Score: 1133
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 2343
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 45 (585 / 0)
  • Genomic Approach to Drug Development (2000)
  • IgE Mediated Hypersensitivity Reaction to Cetuximab (2000)
  • High Gene Copy Number of EGFR by FISH in HNSCC (2000)
 
Honors and Awards: 15 (150 / 0)
  • Fellowship Award for Research in Japan (2009)
  • The Next Generation Award (2008)
  • Impact 2007-2008 recognition (2008)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 9 (81 / 0)
  • Predictive markers of a combination cetuximab and sorafenib response and toxicity (2009)
  • The role of Human Papilloma Virus in deregulation of microRNAs in head and neck squamous cell carcinoma (2008 - 2009)
  • Insulin-like growth factor I receptor as a therapeutic target in non-small cell lung cancer (2008 - 2009)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 34 (204 / 0)
  • Infusion reactions to monoclonal antibodies for solid tumors: Immunologic mechanisms and risk factors (2009)
  • Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications (2009)
  • Evolution of clinical trials in head and neck cancer (2009)
 
Pre/Non Reviewed Papers, Proceedings: 28 (112 / 0)
  • Cetuximab sensitivity in head and neck squamous cell carcinoma cell lines based on the HPV status (2009)
  • Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129 (2009)
  • Mass spectrometry profile as a predictor of overall survival benefit after treatment with epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma. (2009)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 2 (0 / 0)
 
Registered on BiotechScienceNews: 1

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.